본문으로 바로가기

산업동향

Pharmaceutical Industry Profile 2007

  • 등록일2007-03-26
  • 조회수9566
  • 분류산업동향 > 제품 > 바이오의약
  • 자료발간일
    2007-03-26
  • 출처
    http://www.phrma.org
  • 원문링크
  • 키워드
    #Pharmaceutical Industry Profile
  • 첨부파일

Pharmaceutical Industry Profile 2007

 
 
Table of Contents
 
Introduction
 
Pharmaceutical Research Companies: Partners in Improving Health. . . . . . . . . . . . . v
 
Chapter 1
 
Advancing 21st Century Innovation: More Promise, But More Challenges . . . . . . . . 1
  Industry Spending on R&D: Substantial and Growing . . . . . . . . . . . . . . . . . . . . . 2
  Creating Safe and Effective New Medicines: The Potential Has Never Been Greater . 2 
  Today’s R&D Process: Longer, More Complex, and More Costly . . . . . . . . . . . . . . . 3
  The Cost of Innovation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
  The Research and Development Process . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
  Today’s Targets: New Medicines in Development .. . . . . . . . . . . . . . . . . . . . . . 9
  Developing Treatments for Rare Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
  Fostering Innovation . . .  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
  Strong Patent Incentives and Public/Private Cooperation . . . . . . . . . . . . . . . . . 11
  Partners in Innovation: Industry, NIH, Academia .  . . . . . . . . . . . . . . . . . . . . . . 12
  The Biomarkers Consortium. .  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
 
Chapter 2
 
Expanding Access: Empowering Patients to Get the Medicines They Need . . . . . . 15
  Partnership for Prescription Assistance: Free or Nearly Free Medicines for Patients
  in Need. . . .  . . . . . .  . . . . . . . . . . . . . . . . . . . . . . . . . 16
  The Medicare Drug Insurance Program: It’s Working  . . . . . . . . . . . . . . . . . . . 17
  Direct-to-Consumer Advertising: Empowering Access Through Improved   
  Patient/Provider Education . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
 
Chapter 3
Delivering Value: Medicines’ Growing Role in Health Care. . . . . . . . . . . . . . . . . . . . 23
  Today’s More Prominent Role for Medicines . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
  Medicine’s Share of Health Care Spending Remains Small. .  . . . . . . . . . . . . . . . 25
  The Value of Medicines: Improving Lives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
  The Value of Medicines: Addressing Cost Pressures  . . . . . . . . . . . . . . . . . . . . 26
  Getting Full Value from Medicines: Improved Adherence Is Key . . . . . . . . . . . . . . 28
  Prevention and Wellness Initiative: An Industry/Community Partnership to Fight the
  Chronic Disease Crisis. . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
 
Chapter 4
  Helping Those in Need. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
    PhRMA Member Philanthropy Continues to Grow.  . . . . . . . . . . . . . . . . . . 32
    Partnering for Disaster Relief . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
 
Appendix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
   Member Companies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
   PhRMA Annual Membership Survey Definitions of Terms . . . . . . . . . . . . 39
   List of Tables: Detailed Results from the PhRMA Annual Membership Survey  . . 41
 
 
[첨부 파일을 참고하시기 바랍니다]
관련정보

자료 추천하기

받는 사람 이메일
@
메일 내용